- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Paul R. Bessette
News 25 results
Cases & Deals
September 10, 2021
Lexicon Pharmaceuticals, Inc. - 5th Circuit Court of Appeals Affirms Dismissal
Recognition
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Recognition
May 20, 2021
Chambers USA 2021 Names 179 K&S Lawyers and 65 K&S Practice Groups as Leaders in Their Fields
In the News · Source: Business Insurance
May 4, 2021
Paul Bessette comments on contingent liability insurance
Events 5 results
Speaking Engagement
April 28, 2021
Paul Bessette to Speak at PLUS D&O Symposium
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
May 21, 2019
Paul Bessette to Speak at Institute for Energy Law’s 6th Mergers & Acquisitions in Energy Law Conference
Speaking Engagement
May 8, 2019
Paul Bessette to Speak at D&O Insurance ExecuSummit
Insights 17 results
Article · Source: The D&O Diary
May 23, 2021
SPACs and SPAC-Related Litigation: A Primer on Reducing Litigation and Enforcement Risk
Client Alert
August 25, 2020
Court Dismisses Shareholder Suit Seeking To Recover Stock Drop from FDA Nonapproval of Experimental Drug
Article · Source: Bloomberg Law
May 12, 2020
Steps to Limit Exposure to Pharma, PPE Shareholder Lawsuits
Article · Source: Law360
May 4, 2020
Litigation Risks For Energy Executives During Bankruptcy